Hudson, New York — January 12, 2009 - Joseph Phelan, Chairman of the Board of Taconic Farms, Inc. announced today that Todd F. Little, who currently serves as the company's President, has been named Chief Executive Officer (CEO) effective January 1, 2009.
Little succeeds current CEO Samuel P. Phelan, a member of the Phelan family that founded Taconic in 1952. Little has been responsible for leading the day-to-day operations of the company as President since February 2007, succeeding Phelan in that role. His appointment as CEO is another step in a multi-year management continuity program to continuously develop executive talent at Taconic. The appointment of Little to the position of CEO marks the first time in the 50+ year history of the family-owned company that a non-family member has held the CEO position.
While retaining the position of President, Little now takes on the added responsibilities of CEO, which include leading the company's long-range strategic planning, organizational, and executive development, and business development initiatives. He will continue to serve on the governing boards of Taconic's two subsidiaries, Taconic Europe A/S in Denmark and TaconicArtemis GmbH in Germany.
A Taconic employee since 1991, Little has 30 years of experience in the development and production of in vivo models and services for drug discovery and pre-clinical investigations. Prior to Taconic he was Director of Sales and Marketing at Verax and National Sales Manager for Charles River Laboratories. During his tenure at Taconic, he spearheaded Taconic's initial diversification into technical services (e.g. monoclonal antibody production, and genotyping assays) and, as Vice President of Operations, led the construction and startup of the company's newest and most technologically advanced breeding facilities in Cambridge City, IN and Albany, NY.
For a transitional period of approximately six months, Sam Phelan will remain active at Taconic serving in a consultative role for the Senior Management team and as chairman of the governing boards of Taconic's subsidiaries. Later in 2009, Phelan will retire from a 27-year career with Taconic and take on the role of Vice Chairman of the Board of Directors of Taconic Farms, Inc. where he will continue to work closely with Mr. Little.
"The Taconic board is confident that Todd will provide the leadership necessary to continue our company's history of customer service, product innovation, and consistent growth," said Joe Phelan, Chairman of the Board. "Under Todd's leadership, we look forward to enhancing the technological and market leadership for which Taconic is known internationally."
Taconic Farms, Inc. was founded in 1952 as a family-owned business in New York's Hudson River Valley. Since then, the company has become one of the largest laboratory rodent providers in the world with a reputation for consistently producing high quality, well-defined rats and mice. Taconic's expertise in the custom design and generation of genetically modified mice, mouse and rat breeding, barrier systems, genetics, and animal health supports researchers focused on drug development using in vivo models. Taconic has six breeding facilities and three service laboratories in the USA and Europe, a staff of over 1,000, and a commitment to technological innovation.